Literature DB >> 9875186

The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum.

H C Nousari1, W Lynch, G J Anhalt, M Petri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9875186     DOI： 10.1001/archderm.134.12.1509

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  6 in total

Review 1.  Recent advances: Dermatology.

Authors:  P A Foley
Journal:  BMJ       Date:  2000-03-25

Review 2.  Unusual causes of cutaneous ulceration.

Authors:  Jaymie Panuncialman; Vincent Falanga
Journal:  Surg Clin North Am       Date:  2010-12       Impact factor: 2.741

3.  The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room.

Authors:  Hyunhee Park
Journal:  J Clin Aesthet Dermatol       Date:  2011-01

4.  Extraintestinal Complications of Inflammatory Bowel Disease.

Authors:  Ad A. van Bodegraven; Ben A. C. Dijkmans; Paul Lips; Tom J. Stoof; A. Salvador Peña; Stephan G. M. Meuwissen
Journal:  Curr Treat Options Gastroenterol       Date:  2001-06

5.  Pyoderma gangrenosum: From historical perspectives to emerging investigations.

Authors:  Misty M Hobbs; Alex G Ortega-Loayza
Journal:  Int Wound J       Date:  2020-05-06       Impact factor: 3.315

Review 6.  Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview.

Authors:  Kyla Pagani; Danitza Lukac; Aashni Bhukhan; Jean S McGee
Journal:  Am J Clin Dermatol       Date:  2022-04-20       Impact factor: 6.233
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.